Cognex Corporation (NASDAQ:CGNX – Get Free Report) VP Darren Marc Long sold 20,252 shares of the stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the completion of the transaction, the vice president directly owned 3,990 shares in the company, valued at $264,696.60. The trade was a 83.54% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Cognex Stock Performance
CGNX stock opened at $65.85 on Friday. The company’s 50-day simple moving average is $56.97 and its 200 day simple moving average is $47.52. Cognex Corporation has a 52 week low of $29.22 and a 52 week high of $71.90. The company has a market capitalization of $10.96 billion, a PE ratio of 78.39 and a beta of 1.48.
Cognex (NASDAQ:CGNX – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.25 by $0.09. Cognex had a net margin of 13.62% and a return on equity of 10.89%. The business had revenue of $268.44 million for the quarter, compared to the consensus estimate of $245.98 million. During the same period in the prior year, the company posted $0.14 earnings per share. Cognex’s revenue was up 24.3% compared to the same quarter last year. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. On average, analysts forecast that Cognex Corporation will post 1.41 EPS for the current year.
Cognex Dividend Announcement
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on CGNX shares. Needham & Company LLC upped their price target on shares of Cognex from $67.00 to $75.00 and gave the company a “buy” rating in a research note on Friday, May 8th. Weiss Ratings restated a “hold (c)” rating on shares of Cognex in a research note on Friday, May 15th. Robert W. Baird set a $72.00 price target on shares of Cognex in a research note on Friday, May 8th. UBS Group set a $75.00 price target on shares of Cognex in a research note on Tuesday. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $63.00 price objective on shares of Cognex in a research note on Friday, February 13th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, Cognex has an average rating of “Moderate Buy” and an average price target of $70.43.
Get Our Latest Analysis on Cognex
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its holdings in Cognex by 2.1% in the 3rd quarter. Vanguard Group Inc. now owns 18,598,728 shares of the scientific and technical instruments company’s stock valued at $842,522,000 after buying an additional 374,999 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in Cognex by 173,138.2% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 10,477,448 shares of the scientific and technical instruments company’s stock valued at $376,979,000 after buying an additional 10,471,400 shares during the last quarter. Nordea Investment Management AB raised its holdings in Cognex by 0.9% in the 4th quarter. Nordea Investment Management AB now owns 8,101,583 shares of the scientific and technical instruments company’s stock valued at $292,224,000 after buying an additional 76,212 shares during the last quarter. Pictet Asset Management Holding SA raised its holdings in Cognex by 27.9% in the 4th quarter. Pictet Asset Management Holding SA now owns 7,013,184 shares of the scientific and technical instruments company’s stock valued at $252,360,000 after buying an additional 1,529,010 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD raised its holdings in Cognex by 31.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 5,314,896 shares of the scientific and technical instruments company’s stock valued at $191,231,000 after buying an additional 1,258,629 shares during the last quarter. Institutional investors own 88.12% of the company’s stock.
About Cognex
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
Further Reading
- Five stocks we like better than Cognex
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.
